🍽️ montelukast,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Treatment of Gastrointestinal Parasites: Morantel tartrate is effective against various species of gastrointestinal nematodes, including roundworms such as Haemonchus contortus, Teladorsagia circumcincta, Trichostrongylus spp., and Oesophagostomum spp. It works by interfering with the nervous system of the parasites, causing paralysis and expulsion from the host animal's gastrointestinal tract.

  2. Broad-Spectrum Activity: Morantel tartrate has broad-spectrum activity against both adult and larval stages of gastrointestinal nematodes. It is effective against both susceptible and some resistant strains of parasites, making it a valuable tool in parasite control programs for livestock.

  3. Sheep and Goat Parasitism: Morantel tartrate is commonly used in sheep and goats to treat and control infections with gastrointestinal nematodes, which can cause weight loss, poor growth, anemia, diarrhea, and other symptoms in affected animals. Regular deworming with morantel tartrate can help prevent parasitic infestations and improve overall animal health and productivity.

  4. Horse Parasitism: Morantel tartrate is also used in horses to treat and control infections with gastrointestinal parasites such as large and small strongyles, as well as pinworms. Regular deworming with morantel tartrate can help prevent parasitic-related health issues in horses, including colic, weight loss, and poor coat condition.

  5. Safety and Tolerability: Morantel tartrate is generally safe and well-tolerated when used as directed. However, overdosing or misuse of the medication can lead to adverse effects such as gastrointestinal upset, including diarrhea and colic. It's essential to follow the dosage instructions provided by a veterinarian and to accurately estimate the weight of the animal being treated.

  6. Resistance Management: Like other anthelmintic medications, resistance to morantel tartrate can develop in parasite populations over time with frequent and indiscriminate use. To minimize the risk of resistance, veterinarians may recommend implementing strategic deworming programs, rotating between different classes of anthelmintics, and conducting fecal egg count tests to monitor parasite burdens and drug efficacy.

  7. Contraindications: Morantel tartrate should not be used in animals with known hypersensitivity to the drug or in animals intended for human consumption if the withdrawal period has not been observed. Pregnant and lactating animals should be treated with caution, and veterinary guidance should be sought before administering morantel tartrate to these animals.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of montelukast,(prescription) On Probiotics

Rank Probiotic Impact
species Bacteroides uniformis Increases
species Lacticaseibacillus paracasei Reduces
species Parabacteroides distasonis Reduces

Bacteria Impacted by montelukast,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Dorea genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
Ruminococcus genus Decreases 👪 Source Study
Agathobacter genus Decreases 👪 Source Study
Bacteroides genus Decreases 👪 Source Study
Bilophila genus Decreases 👪 Source Study High Level Cause Brain Fog(Cognitive impairment)
Clostridioides genus Decreases 👪 Source Study
Coprococcus genus Decreases 👪 Source Study
Lachnospira genus Decreases 👪 Source Study
Mediterraneibacter genus Decreases 👪 Source Study
Phocaeicola genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Clostridium genus Decreases 👪 Source Study Pathogen
Segatella genus Decreases 👪 Source Study
Enterocloster genus Decreases 👪 Source Study
Blautia genus Decreases 👪 Source Study
Lacticaseibacillus genus Decreases 👪 Source Study
Bacteroides genus Increases 👪 Source Study
Clostridium perfringens A no rank Decreases 👶 Source Study
Clostridium perfringens C no rank Decreases 👶 Source Study
Clostridium perfringens CPE no rank Decreases 👶 Source Study
Clostridium perfringens D no rank Decreases 👶 Source Study
Clostridium perfringens B no rank Decreases 👶 Source Study
Clostridium perfringens E no rank Decreases 👶 Source Study
Dorea formicigenerans species Decreases 📓 Source Study
Ruminococcus bromii species Decreases 📓 Source Study
Agathobacter rectalis species Decreases 📓 Source Study
Bacteroides fragilis species Decreases 📓 Source Study H02076 Bacteroides infection
Bilophila wadsworthia species Decreases 📓 Source Study
Blautia obeum species Decreases 📓 Source Study
Clostridioides difficile species Decreases 📓 Source Study Colitis
Clostridium perfringens species Decreases 📓 Source Study Food poisoning, gas gangrene
Coprococcus comes species Decreases 📓 Source Study
Enterocloster bolteae species Decreases 📓 Source Study
Mediterraneibacter gnavus species Decreases 📓 Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
Parabacteroides merdae species Decreases 📓 Source Study Infectious bacteria
Roseburia intestinalis species Decreases 📓 Source Study
Segatella copri species Decreases 📓 Source Study Over 70%ile Indicator of mycotoxin present
Streptococcus parasanguinis species Decreases 📓 Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Pseudomonas aeruginosa species Decreases 📓 Source Study Opportunistic, nosocomial pneumonia and sepsis
Lacticaseibacillus paracasei species Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
[Ruminococcus] torques species Decreases 📓 Source Study
Lachnospira eligens species Decreases 📓 Source Study
Bacteroides uniformis species Decreases 📓 Source Study Infectious bacteria
Bacteroides thetaiotaomicron species Decreases 📓 Source Study
Bacteroides uniformis species Increases 📓 Source Study Infectious bacteria
Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases 👶 Source Study
Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases 👶 Source Study

Impact of montelukast,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.3 0.3
Acne 0.3 0.2 0.5
ADHD 1.9 0.6 2.17
Age-Related Macular Degeneration and Glaucoma 1.1 0.4 1.75
Allergic Rhinitis (Hay Fever) 2.7 0.9 2
Allergies 4.6 1.7 1.71
Allergy to milk products 0.8 0.4 1
Alopecia (Hair Loss) 1.3 1.3
Alzheimer's disease 2.5 5.2 -1.08
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.6 0.3 4.33
Ankylosing spondylitis 2.5 1.2 1.08
Anorexia Nervosa 1.4 2.6 -0.86
Antiphospholipid syndrome (APS) 0.9 0.3 2
Asthma 3.7 0.8 3.63
Atherosclerosis 1.4 1.5 -0.07
Atrial fibrillation 3.2 1.9 0.68
Autism 6.7 6.1 0.1
Autoimmune Disease 0.3 0.7 -1.33
Barrett esophagus cancer 0.3 -0.3
benign prostatic hyperplasia
Biofilm 2 2
Bipolar Disorder 1.2 1.1 0.09
Brain Trauma 0.3 0.8 -1.67
Cancer (General) 1.3 -1.3
Carcinoma 2 1.4 0.43
Celiac Disease 1.7 2 -0.18
Cerebral Palsy 1 1 0
Chronic Fatigue Syndrome 2.8 6.2 -1.21
Chronic Kidney Disease 2.4 2.2 0.09
Chronic Lyme 0.6 0.5 0.2
Chronic Obstructive Pulmonary Disease (COPD) 2.3 1.4 0.64
Chronic Urticaria (Hives) 0.5 1.2 -1.4
Coagulation / Micro clot triggering bacteria 1.2 1.3 -0.08
Cognitive Function 2.7 1 1.7
Colorectal Cancer 4.6 1.3 2.54
Constipation 0.8 0.7 0.14
Coronary artery disease 1.5 2.2 -0.47
COVID-19 4.2 8 -0.9
Crohn's Disease 5.1 4.2 0.21
Cushing's Syndrome (hypercortisolism) 0.2 -0.2
cystic fibrosis 0.5 0.7 -0.4
deep vein thrombosis 2.4 1.1 1.18
Denture Wearers Oral Shifts 0.9 0.9
Depression 6.2 6.2 0
Dermatomyositis 0.3 0.3
Eczema 1.1 1.7 -0.55
Endometriosis 1.7 1.4 0.21
Eosinophilic Esophagitis 0.3 -0.3
Epilepsy 1.6 1.2 0.33
erectile dysfunction 0.8 0.8
Fibromyalgia 2.8 1.4 1
Functional constipation / chronic idiopathic constipation 3.2 3.3 -0.03
gallstone disease (gsd) 3.3 0.5 5.6
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.8 1.2 -0.5
Generalized anxiety disorder 1.3 1.3 0
giant cell arteritis 0.2 -0.2
Glioblastoma 0.3 -0.3
Gout 0.6 0.8 -0.33
Graves' disease 0.7 2.1 -2
Gulf War Syndrome 0.9 0.6 0.5
Halitosis 0.3 0.3 0
Hashimoto's thyroiditis 2.3 0.7 2.29
Heart Failure 3.4 1.6 1.13
hemorrhagic stroke 1 1
Hidradenitis Suppurativa 1.4 1.4
High Histamine/low DAO 1.3 0.3 3.33
hypercholesterolemia (High Cholesterol) 0.2 0.2
hyperglycemia 0.6 0.6 0
Hyperlipidemia (High Blood Fats) 0.3 0.3
hypersomnia 0.4 -0.4
hypertension (High Blood Pressure 2.8 2.6 0.08
Hypothyroidism 0.5 0.4 0.25
Hypoxia 1.8 0.6 2
IgA nephropathy (IgAN) 1.3 2.1 -0.62
Inflammatory Bowel Disease 4.2 7.2 -0.71
Insomnia 2.4 1.8 0.33
Intelligence 0.5 0.9 -0.8
Intracranial aneurysms 0.9 0.3 2
Irritable Bowel Syndrome 4.2 2.5 0.68
ischemic stroke 1.7 0.8 1.13
Liver Cirrhosis 4.5 2.5 0.8
Long COVID 3.5 4.6 -0.31
Low bone mineral density 1.1 -1.1
Lung Cancer 0.3 1 -2.33
Mast Cell Issues / mastitis 0.8 0.6 0.33
ME/CFS with IBS 1.1 1.9 -0.73
ME/CFS without IBS 1.1 1.8 -0.64
membranous nephropathy 0.3 0.3
Menopause 0.3 0.5 -0.67
Metabolic Syndrome 5.1 3.9 0.31
Mood Disorders 6 5.1 0.18
multiple chemical sensitivity [MCS] 0.9 0.1 8
Multiple Sclerosis 4.2 6 -0.43
Multiple system atrophy (MSA) 0.6 0.4 0.5
myasthenia gravis 0.3 0.7 -1.33
neuropathic pain 1.3 -1.3
Neuropathy (all types) 0.4 1 -1.5
neuropsychiatric disorders (PANDAS, PANS) 0.3 0.3
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2.9 2.8 0.04
NonCeliac Gluten Sensitivity 0.1 0.1
Obesity 5.9 5.1 0.16
obsessive-compulsive disorder 3.6 3.2 0.13
Osteoarthritis 1.2 0.9 0.33
Osteoporosis 1.1 1 0.1
pancreatic cancer 0.3 0.3 0
Parkinson's Disease 5.2 5.3 -0.02
Polycystic ovary syndrome 6 2.4 1.5
Postural orthostatic tachycardia syndrome 0.2 0.3 -0.5
Premenstrual dysphoric disorder 0.1 0.4 -3
primary biliary cholangitis 1.1 0.5 1.2
Primary sclerosing cholangitis 1.5 3.2 -1.13
Psoriasis 2.2 3.1 -0.41
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 5.6 2.9 0.93
Rosacea 0.5 0.7 -0.4
Schizophrenia 2.8 2.5 0.12
scoliosis 0.3 0.7 -1.33
sensorineural hearing loss 0.5 0.5
Sjögren syndrome 1.7 1.4 0.21
Sleep Apnea 2.1 1.3 0.62
Slow gastric motility / Gastroparesis 0.3 0.3
Small Intestinal Bacterial Overgrowth (SIBO) 1.3 1.3
Stress / posttraumatic stress disorder 1.8 1.3 0.38
Systemic Lupus Erythematosus 2.8 1.3 1.15
Tic Disorder 0.8 1.2 -0.5
Tourette syndrome 0.9 0.9
Type 1 Diabetes 2.3 1.8 0.28
Type 2 Diabetes 5.7 3.6 0.58
Ulcerative colitis 3.6 4.1 -0.14
Unhealthy Ageing 4.2 1.9 1.21
Vitiligo 1.9 1.2 0.58

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]